Diamedica Therapeutics Inc. (DMAC)

Market is closed

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on December 02, 2025, 3:47pm based on SEC 13F filings Last update: December 02, 2025, 3:47pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Omega Advisors Leon Cooperman	3,269,761	$17,644,158	+99%	0.55%
2.	Millennium Management Israel Englander	1,187,309	$8,156,813		0%
3.	Citadel Investment Group Ken Griffin	69,352	$476,448		0%
4.	Private Capital Management Gregg J. Powers	50,000	$343,500		0.03%
5.	Marshall Wace LLP Paul Marshall And Ian Wace	39,062	$268,356	-37%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Stahlberg Large Shareholder	$6.00	50,772	$304,632.00	7,764,465	2025-08-27	Filing
Stahlberg Large Shareholder	$6.00	59,648	$357,888.00	7,713,693	2025-08-26	Filing
Stahlberg Large Shareholder	$6.00	338,265	$2,029,251.74	7,654,045	2025-08-25	Filing
Stahlberg Large Shareholder	$5.96	59,788	$356,575.63	7,315,780	2025-08-22	Filing
Stahlberg Large Shareholder	$5.96	48,172	$287,028.04	7,255,992	2025-08-21	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Von Large Shareholder	$1.24	2,855,847	$3,526,971.05	0	2022-12-02	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Blackrock, Inc.	1,678,139	$11,528,816	0%
2.	Paragon Associates & Paragon Associates Ii Joint Venture	875,000	$6,011,250	10.72%
3.	Geode Capital Management, Llc	711,818	$4,891,114	0%
4.	Vanguard Group Inc	664,575	$4,565,630	0%
5.	Morgan Stanley	579,585	$3,981,749	0%